December 2024 FDA Recall Drug by Pd-rx Pharmaceuticals, Inc.
D-0163-2025 - CGMP Deviations
This Class II drug recall was voluntarily initiated by Pd-rx Pharmaceuticals, Inc. on December 4, 2024 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Distributed within US: FL, MS, WI and the recall is currently terminated.
Recall Number: D-0163-2025
CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
12-04-2024
01-01-2025
70, 90-count bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
PD-Rx Pharmaceuticals, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Distributed within US: FL, MS, WI
03-21-2025
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90
Batch or Lot Expiration Information
Lot# I24E77, A24E49, Exp Date: 04/30/25; J23C50, J23C97, L23B39, L23E98, Exp Date: 01/31/2025